Health: pharmaceuticals; reports on certain costs and other information associated with prescription drugs; require manufacturers of prescription drugs to file with the department. Creates new act.

Summary

The bill obligates prescription drug manufacturers to file detailed reports with the state before raising the wholesale acquisition cost of drugs that cost more than $40 per treatment course by 5% in a single year or 15% over three years. It also requires near‑real‑time notice for new specialty drugs and mandates an annual public summary report, imposing civil fines for missed filings.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share